Stockreport

Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day [Yahoo! Finance]

Longeveron Inc. - Class A Common stock  (LGVN) 
PDF Fireside chat with Ash Verma, SMID-cap Biotech & Specialty Pharma Analyst, UBS Equity Research: Date: Tuesday, October 15, 2024 Time: 3:00 p.m. – 3:45 p.m. ET [Read more]